目前，MGMT启动子甲基化状态能否用作多形性胶质母细胞瘤的预后和预测标志物？需谨慎看待。 - Suppr

Suppr

超能文献

Can MGMT promoter methylation status be used as a prognostic and predictive marker for glioblastoma multiforme at the present time? A word of caution.

作者信息

Fietkau R, Putz F, Lahmer G, Semrau S, Buslei R

机构信息

Klinik für Strahlentherapie, Universitätsstr. 27, 91054, Erlangen, Germany,

出版信息

Strahlenther Onkol. 2013 Dec;189(12):993-5. doi: 10.1007/s00066-013-0459-2. Epub 2013 Nov 2.

DOI:10.1007/s00066-013-0459-2

PMID:24177536

Abstract

摘要

相似文献

Can MGMT promoter methylation status be used as a prognostic and predictive marker for glioblastoma multiforme at the present time? A word of caution.

Strahlenther Onkol. 2013 Dec;189(12):993-5. doi: 10.1007/s00066-013-0459-2. Epub 2013 Nov 2.

Relationship between tumor enhancement, edema, IDH1 mutational status, MGMT promoter methylation, and survival in glioblastoma.

AJNR Am J Neuroradiol. 2012 Aug;33(7):1349-55. doi: 10.3174/ajnr.A2950. Epub 2012 Feb 9.

Correlation of apparent diffusion coefficient values measured by diffusion MRI and MGMT promoter methylation semiquantitatively analyzed with MS-MLPA in patients with glioblastoma multiforme.

J Magn Reson Imaging. 2013 Feb;37(2):351-8. doi: 10.1002/jmri.23838. Epub 2012 Sep 28.

The significance of MGMT methylation in Glioblastoma Multiforme prognosis.

J Pak Med Assoc. 2018 Jul;68(7):1137-1139.

The TERT promoter mutation status and MGMT promoter methylation status, combined with dichotomized MRI-derived and clinical features, predict adult primary glioblastoma survival.

Cancer Med. 2018 Aug;7(8):3704-3712. doi: 10.1002/cam4.1666. Epub 2018 Jul 9.

The utilization of MGMT promoter methylation testing in United States hospitals for glioblastoma and its impact on prognosis.

J Clin Neurosci. 2018 May;51:85-90. doi: 10.1016/j.jocn.2018.02.009. Epub 2018 Feb 23.

Defining optimal cutoff value of MGMT promoter methylation by ROC analysis for clinical setting in glioblastoma patients.

J Neurooncol. 2017 May;133(1):193-201. doi: 10.1007/s11060-017-2433-9. Epub 2017 May 17.

[Strategy for studying gene methylation: the example of MGMT].

Ann Pathol. 2009 Nov;29 Spec No 1:S37-9. doi: 10.1016/j.annpat.2009.07.015. Epub 2009 Oct 6.

A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.

Oncotarget. 2015 Oct 6;6(30):29285-95. doi: 10.18632/oncotarget.4978.

IDH1 mutations is prognostic marker for primary glioblastoma multiforme but MGMT hypermethylation is not prognostic for primary glioblastoma multiforme.

Gene. 2015 Jan 1;554(1):81-6. doi: 10.1016/j.gene.2014.10.027. Epub 2014 Oct 14.

引用本文的文献

Expression of LOC285758, a Potential Long Non-coding Biomarker, is Methylation-dependent and Correlates with Glioma Malignancy Grade.

Radiol Oncol. 2017 Jan 14;51(3):331-341. doi: 10.1515/raon-2017-0004. eCollection 2017 Sep.

Recurrent glioblastoma: who receives tumor specific treatment and how often?

J Neurooncol. 2016 May;128(1):85-92. doi: 10.1007/s11060-016-2079-z. Epub 2016 Feb 23.

Radiotherapy of spinal cord gliomas : A retrospective mono-institutional analysis.

Strahlenther Onkol. 2016 Mar;192(3):139-45. doi: 10.1007/s00066-015-0917-0. Epub 2015 Oct 30.

Impact on prognosis of the regional distribution of MGMT methylation with respect to the CpG island methylator phenotype and age in glioma patients.

J Neurooncol. 2015 May;122(3):441-50. doi: 10.1007/s11060-015-1738-9. Epub 2015 Feb 15.

Hippocampal EUD in primarily irradiated glioblastoma patients.

Radiat Oncol. 2014 Dec 6;9:276. doi: 10.1186/s13014-014-0276-5.

Treatment Patterns, Survival, and Healthcare Costs of Patients with Malignant Gliomas in a Large US Commercially Insured Population.

Am Health Drug Benefits. 2014 May;7(3):140-9.

Clinical radiobiology of glioblastoma multiforme: estimation of tumor control probability from various radiotherapy fractionation schemes.

Strahlenther Onkol. 2014 Oct;190(10):925-32. doi: 10.1007/s00066-014-0638-9. Epub 2014 Apr 4.

Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell lines.

Radiat Oncol. 2014 Mar 30;9(1):89. doi: 10.1186/1748-717X-9-89.

The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone.

Neuro Oncol. 2014 Sep;16(9):1263-73. doi: 10.1093/neuonc/nou005. Epub 2014 Feb 6.

本文引用的文献

[Personalized neurooncology].

Nervenarzt. 2013 Aug;84(8):937-42. doi: 10.1007/s00115-013-3758-z.

Clinical neuropathology practice guide 3-2013: levels of evidence and clinical utility of prognostic and predictive candidate brain tumor biomarkers.

Clin Neuropathol. 2013 May-Jun;32(3):148-58. doi: 10.5414/np300646.

Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial.

Lancet Oncol. 2012 Sep;13(9):916-26. doi: 10.1016/S1470-2045(12)70265-6. Epub 2012 Aug 8.

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial.

Lancet Oncol. 2012 Jul;13(7):707-15. doi: 10.1016/S1470-2045(12)70164-X. Epub 2012 May 10.

Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas.

Int J Cancer. 2011 Aug 1;129(3):659-70. doi: 10.1002/ijc.26083.

Comprehensive analysis of MGMT promoter methylation: correlation with MGMT expression and clinical response in GBM.

PLoS One. 2011 Jan 7;6(1):e16146. doi: 10.1371/journal.pone.0016146.

Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.

Clin Cancer Res. 2009 Nov 1;15(21):6683-93. doi: 10.1158/1078-0432.CCR-08-2801. Epub 2009 Oct 27.

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Lancet Oncol. 2009 May;10(5):459-66. doi: 10.1016/S1470-2045(09)70025-7. Epub 2009 Mar 9.

Validation of real-time methylation-specific PCR to determine O6-methylguanine-DNA methyltransferase gene promoter methylation in glioma.

J Mol Diagn. 2008 Jul;10(4):332-7. doi: 10.2353/jmoldx.2008.070169. Epub 2008 Jun 13.

The role of radio- and chemotherapy in glioblastoma.

Onkologie. 2005 Jun;28(6-7):315-7. doi: 10.1159/000085575. Epub 2005 Jun 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验